Kang-Yi Su Selected Research

Kang-Yi Su Research Topics

Disease

27	Neoplasms (Cancer) 10/2023 - 09/2006
22	Adenocarcinoma of Lung 11/2023 - 04/2011
14	Lung Neoplasms (Lung Cancer) 11/2023 - 04/2011
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2012
7	Neoplasm Metastasis (Metastasis) 11/2023 - 11/2012
4	Adenocarcinoma 01/2020 - 10/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017 - 01/2016
2	Carcinogenesis 08/2014 - 09/2006
1	Shock 01/2022
1	Sepsis (Septicemia) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 08/2021
1	Colonic Neoplasms (Colon Cancer) 06/2020
1	Colorectal Neoplasms (Colorectal Cancer) 06/2020
1	Invasive Fungal Infections 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Disease Progression 01/2018
1	Melanoma (Melanoma, Malignant) 10/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Testicular Neoplasms (Testicular Cancer) 07/2016
1	Lymphoma (Lymphomas) 04/2016
1	Stroke (Strokes) 01/2016
1	Cerebral Infarction 01/2016
1	Ischemia 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2014
1	Fibrosis (Cirrhosis) 04/2014
1	Inflammation (Inflammations) 01/2014
1	Fatigue 01/2014

Drug/Important Bio-Agent (IBA)

23	ErbB Receptors (EGF Receptor)IBA 11/2023 - 04/2011
18	Tyrosine Kinase InhibitorsIBA 04/2022 - 04/2011
7	osimertinibIBA 01/2023 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2014
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2006
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 04/2015
3	AfatinibIBA 01/2023 - 01/2022
3	B7-H1 AntigenIBA 01/2022 - 01/2020
3	LigandsIBA 01/2022 - 07/2018
2	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2023
2	Gefitinib (Iressa)FDA Link 04/2022 - 04/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2022 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
2	AntigensIBA 10/2017 - 07/2016
2	Propolis (Bee Bread)IBA 01/2016 - 04/2014
2	FlavonoidsIBA 01/2016 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 04/2011
2	hepsinIBA 11/2012 - 09/2006
1	AdipokinesIBA 11/2023
1	C-Reactive ProteinIBA 11/2023
1	CytokinesIBA 11/2023
1	ProteomeIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 04/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	InterferonsIBA 01/2022
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2022
1	exodeoxyribonuclease IIBA 01/2022
1	EndotoxinsIBA 01/2022
1	Prealbumin (Transthyretin)IBA 08/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2020
1	Calcibiotic Root Canal SealerIBA 06/2020
1	CrizotinibIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	TriazolesIBA 01/2019
1	Voriconazole (Vfend)FDA LinkGeneric 01/2019
1	SynaptophysinIBA 11/2018
1	Retinoblastoma ProteinIBA 11/2018
1	Chromogranin AIBA 11/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	NivolumabIBA 01/2018
1	pembrolizumabIBA 01/2018
1	FructoseIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2017
1	NucleotidesIBA 01/2017
1	SaltsIBA 04/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Terpenes (Terpenoids)IBA 01/2016
1	Nucleic AcidsIBA 04/2015
1	Peptide Nucleic AcidsIBA 04/2015
1	OligonucleotidesIBA 01/2015
1	CateninsIBA 08/2014
1	propolin GIBA 04/2014
1	Alanine Transaminase (SGPT)IBA 04/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	Advanced Glycation End ProductsIBA 01/2014
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2014
1	PlatinumIBA 01/2014
1	Rutin (Rutoside)IBA 01/2014
1	Superoxide DismutaseIBA 01/2014
1	Malondialdehyde (Propanedial)IBA 01/2014
1	GlycogenIBA 01/2014
1	Glutathione PeroxidaseIBA 01/2014
1	EnzymesIBA 01/2014

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2013
4	Immunotherapy 01/2023 - 01/2018
1	Aftercare (After-Treatment) 01/2018